Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Leukemia
Study Phase
Phase 3
Study Completion Date
July 2016
NCT00651261Uploaded 04-28-2020
Access via NCI by Request
PDS UID: nci-data-409
A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
Files: NCT00651261-D1
Data DictionaryNCT00651261-D1-Data-Dictionary_1.pdf
DATANCT00651261-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00651261-D2
Data DictionaryNCT00651261-D2-Data-Dictionary_1.pdf
DATANCT00651261-D2-Dataset_2.csv
OTHERREADME.pdf
Files: NCT00651261-D3
Data DictionaryNCT00651261-D3-Data-Dictionary_2.pdf
DATANCT00651261-D3-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00651261-D4
Data DictionaryNCT00651261-D4-Data-Dictionary_3.pdf
DATANCT00651261-D4-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00651261-D5
Data DictionaryNCT00651261-D5-Data-Dictionary_2.pdf
DATANCT00651261-D5-Dataset_1.csv
OTHERREADME.pdf